Login / Signup

Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.

Yun Yeong KimSe Jeong OhYong Soon ChunWoon Kee LeeHeung Kyu Park
Published in: PloS one (2018)
Our collective findings indicate that WFO without the gene expression assay has limited clinical utility.
Keyphrases
  • gene expression
  • dna methylation
  • high throughput
  • palliative care
  • breast cancer cells
  • young adults